Published in Volume
114, Issue 1 (July 1, 2004)
J Clin Invest. 2004;114(1):142–142.
doi:10.1172/JCI17740C1.
Copyright ©
2004, The American Society for
Clinical Investigation.
Corrigendum
Cathepsin B inactivation attenuates hepatic injury and fibrosis
during cholestasis
Ali Canbay, Maria Eugenia Guicciardi, Hajime Higuchi, Ariel Feldstein, Steven F. Bronk, Robert Rydzewski, Makiko Tanai and Gregory J. Gores
Published July 1, 2004
Original citation: J. Clin. Invest.
112:152–159(2004). doi:10.1172/JCI17740.
Citation for this Corrigendum: J. Clin. Invest.
114:142 (2004). doi:10.1172/JCI17740C1.
The authors wish to correct errors and provide further clarification regarding this
manuscript. Figure 2a was reproduced from a previous publication (Canbay et al.
Gastroenterology. 123:1323–1330
[2002]). An appropriate photomicrograph from concurrent control
mice is depicted below and should replace the original.
In addition, although wild-type and cathepsin B–/–
mice originated from the same litter, they were subsequently bred as homozygotes for
this study and therefore were not concurrent littermates as was indicated in the study.
